RT Journal Article
SR Electronic
T1 Estimating population immunity without serological testing
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.23.20076786
DO 10.1101/2020.04.23.20076786
A1 Andrew Lesniewski
YR 2020
UL http://medrxiv.org/content/early/2020/04/26/2020.04.23.20076786.abstract
AB We propose an approximate methodology for estimating the overall level of immunity against COVID-19 in a population that has been affected by the recent epidemic. The methodology relies on the currently available mortality data and utilizes the properties of the SIR model. We illustrate the application of the method by estimating the recent levels of immunity in 10 US states with highest case numbers of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research did not use outside funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used is in public domain (Worldometer.com).